|
Bhattacharyya, Swati; Varga, John (2018) Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy. Immunol Lett 195:9-17
|
|
Cooper, John G; Jeong, Su Ji; McGuire, Tammy L et al. (2018) Fibronectin EDA forms the chronic fibrotic scar after contusive spinal cord injury. Neurobiol Dis 116:60-68
|
|
Korman, Benjamin; Marangoni, Roberta Goncalves; Lord, Gabriel et al. (2018) Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis. Arthritis Res Ther 20:145
|
|
Marangoni, Roberta G; Masui, Yuri; Fang, Feng et al. (2017) Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target. Sci Rep 7:4397
|
|
Wei, Jun; Zhu, Hongyan; Lord, Gabriel et al. (2017) Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative. Transl Res 183:71-86.e1
|
|
Bhattacharyya, Swati; Wang, Wenxia; Morales-Nebreda, Luisa et al. (2016) Tenascin-C drives persistence of organ fibrosis. Nat Commun 7:11703
|
|
Reinke, Lauren; Lam, Anna P; Flozak, Annette S et al. (2016) Adiponectin inhibits Wnt co-receptor, Lrp6, phosphorylation and ?-catenin signaling. Biochem Biophys Res Commun 470:606-612
|
|
Bhattacharyya, Swati; Wang, Wenxia; Graham, Lauren Van Duyn et al. (2016) A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator. Arthritis Res Ther 18:216
|
|
Hinchcliff, Monique E; Beaumont, Jennifer L; Carns, Mary A et al. (2015) Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis. J Rheumatol 42:64-72
|
|
Taroni, Jaclyn N; Martyanov, Viktor; Huang, Chiang-Ching et al. (2015) Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures. Arthritis Res Ther 17:194
|
Showing the most recent 10 out of 90 publications
